Differential diagnosis of lung cancer and benign lung lesion using salivary metabolites: A preliminary study

BACKGROUND: Saliva is often used as a biomarker for the diagnosis of some oral and systematic diseases, owing to the non‐invasive attribute of the fluid. In this study, we aimed to identify salivary biomarkers for distinguishing lung cancer (LC) from benign lung lesion (BLL). MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Takamori, Satoshi, Ishikawa, Shigeo, Suzuki, Jun, Oizumi, Hiroyuki, Uchida, Tetsuro, Ueda, Shohei, Edamatsu, Kaoru, Iino, Mitsuyoshi, Sugimoto, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807259/
https://www.ncbi.nlm.nih.gov/pubmed/34918488
http://dx.doi.org/10.1111/1759-7714.14282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807259/
https://www.ncbi.nlm.nih.gov/pubmed/34918488
http://dx.doi.org/10.1111/1759-7714.14282

Ejemplares similares